Table 2.
Association Analyses of T2DM Susceptibility Genes With NODAT
Frequency of High-Risk Allele |
||||||
---|---|---|---|---|---|---|
Gene | SNP | Alleles* | Cases (%) | Controls (%) | Odds Ratio (95% CI)† | Odds Ratio (95% CI)‡ |
TCF7L2 | rs12255372 | G/T | 20.4 | 18.8 | 1.10 (0.48–2.52) | 0.98 (0.41–2.30) |
TCF7L2 | rs7901695 | T/C | 27.3 | 24.6 | 1.12 (0.54–2.32) | 0.98 (0.45–2.14) |
KCNJ11 | rs5219 | C/T | 36.3 | 35.5 | 1.03 (0.52–2.01) | 0.93 (0.45–1.94) |
KCNJ11 | rs5215 | C/T | 63.6 | 62.3 | 1.05 (0.54–2.02) | 1.15 (0.56–2.36) |
PPARG | rs1801282 | G/C | 86.3 | 86.9 | 0.96 (0.39–2.34) | 1.02 (0.36–2.85) |
SLC30A8 | rs13266634 | T/C | 77.2 | 73.9 | 1.19 (0.54–2.57) | 1.17 (0.48–2.84) |
CDKN2A/CDKN2B | rs10811661 | C/T | 79.5 | 80.4 | 0.95 (0.435–2.13) | 1.42 (0.55–3.58) |
CDKN2A/CDKN2B | rs564398 | G/A | 63.6 | 66 | 0.91 (0.45–1.81) | 1.20 (0.54–2.66) |
IGF2BP2 | rs4402960 | G/T | 31.8 | 24.6 | 1.44 (0.67–3.07) | 1.16 (0.51–2.63) |
IGF2BP2 | rs1470579 | A/C | 36.3 | 29.7 | 1.31 (0.66–2.59) | 1.21 (0.56–2.60) |
CDKAL1 | rs10946398 | A/C | 34.1 | 27.5 | 1.38 (0.65–2.91) | 1.84 (0.79–4.28) |
CDKAL1 | rs7756992 | A/G | 31.8 | 26.1 | 1.39 (0.61–3.17) | 2.06 (0.81–5.28) |
CDKAL1 | rs7754840 | G/C | 34.1 | 30.4 | 1.19 (0.57–2.50) | 1.69 (0.72–3.95) |
HHEX | rs1111857 | A/G | 63.6 | 60.8 | 1.11 (0.57–2.16) | 1.33 (0.66–2.69) |
HHEX | rs5015480 | T/C | 61.4 | 57.2 | 1.14 (0.61–2.15) | 1.32 (0.67–2.58) |
Multiallelic risk | 1.10 (0.89–1.35) | 1.06 (0.82–1.38) |
Underlined and bold alleles are diabetes-associated alleles as described in prior studies.
Odds ratio (unadjusted) per copy of the risk allele.
Odds ratio: adjusted (age, gender, race) per copy of the risk allele.